Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis Volkhard Heinrichs NFORMACIÓN AL CLIENTESALA DE AUTORESSALA

NFORMACIÓN AL CLIENTESALA DE AUTORESSALA DEL ESTUDIANTEDPBLOGContactoMi cuentaCarritoBusca por ISBN

Dentro de su interior sucedía algo misterioso

abocados a la inmigración

percibir con imparcialidad la realidad

Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis Volkhard Heinrichs NFORMACIÓN AL CLIENTESALA DE AUTORESSALADeveloping and Strengthening the Global Supply Chain for Second Line Drugs for Multidrug Resistant Tuberculosis To effectively treat patients diagnosed with drug resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality assured (QA), second line anti TB drugs (SLDs) is necessary. Patients diagnosed with multidrug resistant tuberculosis (MDR TB)a disease caused